ESMO 2026 | Dr. Patrizia Giannatempo on Treatment De-escalation and Precision Oncology

At ESMO26, Dr. Patrizia Giannatempo examines the challenges of treatment de-escalation in highly curable cancers, including germ cell tumors, where reducing treatment burden must be balanced against the risk of compromising long-term outcomes.

Library